BCEIE › News
Market news from company filings
Stories on important NSE and BSE disclosures: what was filed, how big it is for the company, and how the stock reacted to similar filings before.
- ApprovalGLOBALE
Globale Tessile: Kindly take note that the Meeting of the Board of Directors of the Company, held on Friday, October 30,…
Globale Tessile (GLOBALE) filed a disclosure titled "Kindly take note that the Meeting of the Board of Directors of the Company, held on Friday, October 30, 2026, at the Registered Office of the Company, has considered and approved…". The company is valued…
- ApprovalTIMKEN
Timken India: In furtherance to our earlier communication dated 13 July, 2026, please find attached press release…
Timken India (TIMKEN) filed a disclosure titled "In furtherance to our earlier communication dated 13 July, 2026, please find attached press release regarding BIS Licenses obtained by Timken India Limited". The company is valued at about ₹21,452 crore.
- ApprovalAPLLTD
Alembic Pharmaceuticals: Receives USFDA Final Approval for Venetoclax Tablets, 10 mg, 50 mg and 100 mg
Alembic Pharmaceuticals (APLLTD) filed a disclosure titled "Receives USFDA Final Approval for Venetoclax Tablets, 10 mg, 50 mg and 100 mg". The company is valued at about ₹15,387 crore.
- ApprovalCRIZAC
Crizac: The Board of Directors of the Company at their Meeting held today i.e., Friday, October 30, 2026 has…
Crizac (CRIZAC) filed a disclosure titled "The Board of Directors of the Company at their Meeting held today i.e., Friday, October 30, 2026 has inter-alia, considered and approved the 1. The company is valued at about ₹2,511 crore.
- ApprovalBRIGHTBR
Bright Brothers: The Board of Directors of the Company at its meeting held today, has inter alia considered and approved the…
Bright Brothers (BRIGHTBR) filed a disclosure titled "The Board of Directors of the Company at its meeting held today, has inter alia considered and approved the following: a) Unaudited Financial Statements (Standalone and…". The company is valued at about…
- ApprovalONESOURCE
Onesource Specialty Pharma: OneSource receives USFDA EIR with VAI Classification, Marking completion of Inspection process at its…
Onesource Specialty Pharma (ONESOURCE) filed a disclosure titled "OneSource receives USFDA EIR with VAI Classification, Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru". The company is valued at about…
- ApprovalAFIL
Akme Fintrade (India): The receipt of trading approval for 82,00,000 Equity Shares having face value of Rs.1/- (Rupees One Only)…
Akme Fintrade (India) (AFIL) filed a disclosure titled "The receipt of trading approval for 82,00,000 Equity Shares having face value of Rs.1/- (Rupees One Only) each allotted". The company is valued at about ₹313 crore.
- ApprovalSUNPHARMA
Sun Pharmaceutical Industries: ILUMYA® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis
Sun Pharmaceutical Industries (SUNPHARMA) filed a disclosure titled "ILUMYA® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis". The company is valued at about ₹4.23 lakh crore.
- ApprovalHUBTOWN
Hubtown: At the meeting of the Board of Directors of the Company held today i.e. October 29, 2026, the Board has…
Hubtown (HUBTOWN) filed a disclosure titled "At the meeting of the Board of Directors of the Company held today i.e. October 29, 2026, the Board has inter-alia approved and taken on record the Unaudited". The company is valued at about ₹2,613 crore.
- ApprovalPARADEEP
Paradeep Phosphates: The Board of Directors of the Company at its meeting held today, i.e., October 29, 2026, inter alia, has…
Paradeep Phosphates (PARADEEP) filed a disclosure titled "The Board of Directors of the Company at its meeting held today, i.e., October 29, 2026, inter alia, has considered and approved the Unaudited standalone and consolidated". The company is valued at…
- ApprovalAHCL
Anlon Healthcare: Intimation of receipt of 'In-Principle' Approval
Anlon Healthcare (AHCL) filed a disclosure titled "Intimation of receipt of 'In-Principle' Approval". The company is valued at about ₹1,335 crore.
- ApprovalSAMBHV
Sambhv Steel Tubes: In the meeting held on October 29, 2026, the board has approved the new project of its wholly owned subsidiary
Sambhv Steel Tubes (SAMBHV) filed a disclosure titled "In the meeting held on October 29, 2026, the board has approved the new project of its wholly owned subsidiary". The company is valued at about ₹4,967 crore.
- ApprovalCENTENKA
Century Enka: Receipt of Approval under the Production Linked Incentive (PLI) Scheme for Textiles'
Century Enka (CENTENKA) filed a disclosure titled "Receipt of Approval under the Production Linked Incentive (PLI) Scheme for Textiles'". The company is valued at about ₹1,035 crore.
- ApprovalSOUTHWEST
South West Pinnacle Exploration: Intimation regarding receipt of Trading Approval from NSE and BSE for Trading of 28, 21, 411 Equity Shares…
South West Pinnacle Exploration (SOUTHWEST) filed a disclosure titled "Intimation regarding receipt of Trading Approval from NSE and BSE for Trading of 28, 21, 411 Equity Shares allotted pursuant to conversion of Share Warrants issued preferential…". The…
- ApprovalAEROFLEX
Aeroflex Industries: The Board of Directors of the Company at its meeting held today, i.e. Wednesday, October 28, 2026,…
Aeroflex Industries (AEROFLEX) filed a disclosure titled "The Board of Directors of the Company at its meeting held today, i.e. Wednesday, October 28, 2026, inter-alia, transacted the following business: 1. The company is valued at about ₹6,514 crore.
- ApprovalSUPREME
Supreme Holdings & Hospitality (India): The Board of Directors of the Company at its Meeting held on October 28, 2026 has considered and approved…
Supreme Holdings & Hospitality (India) (SUPREME) filed a disclosure titled "The Board of Directors of the Company at its Meeting held on October 28, 2026 has considered and approved following: 1. The company is valued at about ₹102 crore.
- ApprovalNAUKRI
Info Edge (India): The Board of Directors of the Company at their meeting held today i.e. on Wednesday, October 28, 2026, have,…
Info Edge (India) (NAUKRI) filed a disclosure titled "The Board of Directors of the Company at their meeting held today i.e. on Wednesday, October 28, 2026, have, inter alia, considered and approved the unaudited Standalone &…". The company is valued at…
- ApprovalSTARHEALTH
Star Health and Allied Insurance Company: Star Health and Allied Insurance Company Limited ('Company'), in their meeting held on Tuesday, October 27,…
Star Health and Allied Insurance Company (STARHEALTH) filed a disclosure titled "Star Health and Allied Insurance Company Limited ('Company'), in their meeting held on Tuesday, October 27, 2026 inter alia, had considered and approved the unaudited…
- ApprovalJSWCEMENT
JSW Cement: Board of Directors of JSW Cement Limited has, in its meeting held today i.e. on Tuesday, 27th October, 2026,…
JSW Cement (JSWCEMENT) filed a disclosure titled "Board of Directors of JSW Cement Limited has, in its meeting held today i.e. on Tuesday, 27th October, 2026, inter alia considered and approved (i) Unaudited". The company is valued at about ₹15,898 crore.
- ApprovalCANBK
Canara Bank: Exercising of Call Option of Basel III Complaint Additional Tier I Bond (ISIN: INE476A08134)- RBI Approval
Canara Bank (CANBK) filed a disclosure titled "Exercising of Call Option of Basel III Complaint Additional Tier I Bond (ISIN: INE476A08134)- RBI Approval". The company is valued at about ₹1.07 lakh crore.
- ApprovalINDOCO
Indoco Remedies: Indoco's Clinical Research Orgainsation - AnaCipher receives approval from ANVISA Brazil for its clinical…
Indoco Remedies (INDOCO) filed a disclosure titled "Indoco's Clinical Research Orgainsation - AnaCipher receives approval from ANVISA Brazil for its clinical and bioanalytical facilities". The company is valued at about ₹2,091 crore.
- ApprovalAPLLTD
Alembic Pharmaceuticals: Alembic Pharmaceuticals Limited receives USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL
Alembic Pharmaceuticals (APLLTD) filed a disclosure titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL". The company is valued at about ₹14,941 crore.
- ApprovalSKYGOLD
SKY GOLD AND DIAMONDS: The Board of Directors of the Company ('Board') in its meeting held today, i.e. Tuesday, 27th October 2026…
SKY GOLD AND DIAMONDS (SKYGOLD) filed a disclosure titled "The Board of Directors of the Company ('Board') in its meeting held today, i.e. Tuesday, 27th October 2026 has inter alia considered and approved the following: 01". The company is valued at about…
- ApprovalKFINTECH
Kfin Technologies: Intimation for Grant of Foreign Business License to KFin Technologies (Thailand) Limited, a subsidiary of…
Kfin Technologies (KFINTECH) filed a disclosure titled "Intimation for Grant of Foreign Business License to KFin Technologies (Thailand) Limited, a subsidiary of the Company". The company is valued at about ₹14,854 crore.
- ApprovalEVERESTIND
Everest Industries: The Board of Directors of the Company at its meeting held today, i.e. on October 26, 2026, has inter-alia,…
Everest Industries (EVERESTIND) filed a disclosure titled "The Board of Directors of the Company at its meeting held today, i.e. on October 26, 2026, has inter-alia, considered and approved Unaudited Standalone and Consolidated". The company is valued at…
- ApprovalDCMSHRIRAM
DCM Shriram: The Board approved capital expenditures as per the attachment
DCM Shriram (DCMSHRIRAM) filed a disclosure titled "The Board approved capital expenditures as per the attachment". The company is valued at about ₹15,041 crore.
- ApprovalPTC
PTC India: The Board of PTC in its meeting held on 26th October 2026 approved the incorporation of wholly owned…
PTC India (PTC) filed a disclosure titled "The Board of PTC in its meeting held on 26th October 2026 approved the incorporation of wholly owned subsidiary for setting up mineral exchange, as per attached disclosure". The company is valued at about ₹3,948…
- ApprovalSUDEEPPHRM
Sudeep Pharma: Press Release - FDA Approval for the new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat
Sudeep Pharma (SUDEEPPHRM) filed a disclosure titled "Press Release - FDA Approval for the new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat". The company is valued at about ₹10,907 crore.
- ApprovalWEALTH
Wealth First Portfolio Managers: OUTCOME OF 05/2026-27 BOARD MEETING DATED 26 TH OCTOBER, 2026, DISCLOSURE
Wealth First Portfolio Managers (WEALTH) filed a disclosure titled "OUTCOME OF 05/2026-27 BOARD MEETING DATED 26 TH OCTOBER, 2026, DISCLOSURE". The company is valued at about ₹897 crore.
- ApprovalBIOCON
Biocon: Company Statement
Biocon (BIOCON) filed a disclosure titled "Company Statement". The company is valued at about ₹52,721 crore.
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.